{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:16:51Z","timestamp":1792441011901,"version":"4.5.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T00:00:00Z","timestamp":1381708800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077298","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T21:02:04Z","timestamp":1381784524000},"page":"e77298","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses"],"prefix":"10.1371","volume":"8","author":[{"given":"Abeba","family":"Tesfaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Stift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Maric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Dienes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Feinstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of Hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"GL Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s10900-011-9507-y","article-title":"An Analysis of Content in Comprehensive Cancer Control Plans that Address Chronic Hepatitis B and C Virus Infections as Major Risk Factors for Liver Cancer","volume":"37","author":"B Momin","year":"2012","journal-title":"J Community Health"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1440-1746.2011.06723.x","article-title":"Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection","volume":"26","author":"T Yamashita","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/onc.2010.594","article-title":"Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer","volume":"30","author":"DR McGivern","year":"2011","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"A Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"P Peter Simmonds","year":"2005","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2012.02.016","article-title":"Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease","volume":"142","author":"J Bukh","year":"2012","journal-title":"Gastroenterology"},{"key":"ref7","first-page":"49","article-title":"Animal models for hepatitis C","volume":"369","author":"E Billerbeck","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"M Houghton","year":"2011","journal-title":"Immunol Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa1104430","article-title":"Preliminary study of two antiviral agents for hepatitis C genotype 1","volume":"366","author":"AS Lok","year":"2012","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(10)61384-0","article-title":"Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"376","author":"EJ Gane","year":"2010","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.24724","article-title":"Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders","volume":"55","author":"K Chayama","year":"2012","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"DF Mercer","year":"2001","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1073\/pnas.95.1.310","article-title":"Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma","volume":"95","author":"J Petersen","year":"1998","journal-title":"Proc Natl Acad Sci U_S_A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhep.2010.03.024","article-title":"Factors determining successful engraftment of hepatocytes and susceptibility of hepatitis B and C virus infection in uPA-SCID mice","volume":"53","author":"T Vanwolleghem","year":"2010","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3727\/096368908786516800","article-title":"Rescue of Fertility in Homozygous Mice for the Urokinase Plasminogen Activator Transgene by the Transplantation of Mouse Hepatocytes","volume":"17","author":"NM Brezillon","year":"2008","journal-title":"Cell Transplant"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"H Azuma","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice","volume":"7","author":"M Grompe","year":"1993","journal-title":"Genes Dev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"M Grompe","year":"1995","journal-title":"Nat Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide A model for hepatitis B and C virus infection and treatment","volume":"120","author":"KD Bissig","year":"2010","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/S0002-9440(10)64835-3","article-title":"Hepatocyte transplantation into diseased mouse liver: Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes","volume":"157","author":"TC Weglarz","year":"2000","journal-title":"Am J Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/hep.21441","article-title":"Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver","volume":"44","author":"J Heo","year":"2006","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/651579","article-title":"Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver chimeric mouse models","volume":"201","author":"J Bukh","year":"2010","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/infdis\/147.3.531","article-title":"Use of and Interpretation of Results Using Inocula of Hepatitis B Virus with Known Infectivity Titers","volume":"147","author":"E Tabor","year":"1983","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"BD Lindenbach","year":"2005","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0166-0934(02)00119-2","article-title":"Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay","volume":"105","author":"M Puig","year":"2002","journal-title":"J Virol Methods"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/JVI.73.4.3317-3325.1999","article-title":"Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus","volume":"73","author":"ME Major","year":"1999","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge","volume":"76","author":"ME Major","year":"2002","journal-title":"J Virol"},{"key":"ref28","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"ref29","year":"2011"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.2008.03753.x","article-title":"Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment","volume":"154","author":"T Pearson","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/1074-7613(95)90047-0","article-title":"Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain","volume":"2","author":"X Cao","year":"1995","journal-title":"Immunity"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"P Mombaerts","year":"1992","journal-title":"Cell"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T23:53:38Z","timestamp":1596671618000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077298"}},"subtitle":[],"editor":[{"given":"Ranjit","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,14]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077298","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,14]]}}}